Holen Sie sich die Stockscreener-App
121.93
1.82%
2.18
Handel nachbörslich:
121.56
-0.37
-0.30%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$119.75
Offen:
$120.76
24-Stunden-Volumen:
13.08M
Relative Volume:
0.91
Marktkapitalisierung:
$302.63B
Einnahmen:
$65.00B
Nettoeinkommen (Verlust:
$18.26B
KGV:
16.76
EPS:
7.2751
Netto-Cashflow:
$13.05B
1W Leistung:
+10.57%
1M Leistung:
+12.00%
6M Leistung:
+53.49%
1J Leistung:
+38.48%
1-Tages-Spanne:
$120.44
$122.66
1-Wochen-Bereich:
$109.95
$122.66
52-Wochen-Spanne:
$73.31
$122.66
Merck Co Inc Stock (MRK) Company Profile
Firmenname
Merck Co Inc
Sektor
Telefon
908-740-4000
Adresse
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK vs LLY, JNJ, ABBV, AZN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
121.93 | 297.22B | 65.00B | 18.26B | 13.05B | 7.2751 |
|
LLY
Lilly Eli Co
|
1,058.18 | 913.67B | 65.18B | 20.64B | 6.44B | 22.96 |
|
JNJ
Johnson Johnson
|
239.99 | 572.91B | 94.19B | 26.80B | 20.46B | 11.05 |
|
ABBV
Abbvie Inc
|
223.43 | 387.09B | 61.16B | 4.20B | 19.68B | 2.3671 |
|
AZN
Astrazeneca Plc
|
193.03 | 290.15B | 58.07B | 9.40B | 9.87B | 3.0115 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-08 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-18 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-10-13 | Fortgesetzt | Citigroup | Neutral |
| 2025-09-17 | Herabstufung | Berenberg | Buy → Hold |
| 2025-05-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-04-22 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-08 | Herabstufung | Truist | Buy → Hold |
| 2024-12-20 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Fortgesetzt | BofA Securities | Buy |
| 2024-12-04 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-11 | Herabstufung | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-03-11 | Herabstufung | Societe Generale | Hold → Sell |
| 2024-01-04 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-27 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-14 | Eingeleitet | HSBC Securities | Hold |
| 2023-04-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-03-28 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-03-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Eingeleitet | Jefferies | Buy |
| 2023-02-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Outperform |
| 2022-10-10 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-09-14 | Hochstufung | Berenberg | Hold → Buy |
| 2022-07-06 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Fortgesetzt | SVB Leerink | Outperform |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Eingeleitet | Goldman | Buy |
| 2021-12-16 | Eingeleitet | Daiwa Securities | Neutral |
| 2021-12-13 | Herabstufung | UBS | Buy → Neutral |
| 2021-12-09 | Eingeleitet | Wells Fargo | Overweight |
| 2021-12-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-11-29 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-11-01 | Hochstufung | Argus | Hold → Buy |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Fortgesetzt | Truist | Buy |
| 2021-05-20 | Herabstufung | Argus | Buy → Hold |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Fortgesetzt | Bernstein | Outperform |
| 2020-09-29 | Eingeleitet | Berenberg | Hold |
| 2020-08-03 | Hochstufung | Goldman | Neutral → Buy |
| 2020-06-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-01-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-16 | Eingeleitet | SVB Leerink | Outperform |
| 2019-07-03 | Eingeleitet | Mizuho | Buy |
| 2019-05-28 | Eingeleitet | Goldman | Neutral |
| 2019-05-13 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Bestätigt | Citigroup | Buy |
| 2018-10-09 | Fortgesetzt | Guggenheim | Buy |
| 2018-04-23 | Hochstufung | Goldman | Neutral → Buy |
| 2018-04-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-02-07 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Hochstufung | SunTrust | Hold → Buy |
Alle ansehen
Merck Co Inc Aktie (MRK) Neueste Nachrichten
3 Top Dow Jones Dividend Stocks to Buy for Passive Income in 2026 - The Motley Fool
Merck & Co., Inc. (NYSE:MRK) Cut to "Buy" at Wall Street Zen - MarketBeat
Merck stock ends week near highs after Canada clears ENFLONSIA; insider sales surface - TechStock²
Merck & Co., Inc. (MRK): A Bull Case Theory - Insider Monkey
Merck & Co., Inc. $MRK Shares Bought by Canada Post Corp Registered Pension Plan - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Garland Capital Management Inc. - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Prime Capital Investment Advisors LLC - MarketBeat
Insider Sell Alert: Johannes Oosthuizen Sells 15,000 Shares of M - GuruFocus
Merck & Co., Inc. (NYSE:MRK) EVP David Michael Williams Sells 5,000 Shares - MarketBeat
Johannes Jacobus Oosthuizen Sells 15,000 Shares of Merck & Co., Inc. (NYSE:MRK) Stock - MarketBeat
Merck & Co., Inc. (NYSE:MRK) CFO Caroline Litchfield Sells 41,997 Shares - MarketBeat
Merck And Company Inc (NYSE:MRK) Healthcare Momentum In S&P 500 Today - Kalkine Media
Merck & Co., Inc. (NYSE:MRK) Shares Up 1.8% Following Analyst Upgrade - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $140.00 - MarketBeat
Willis Investment Counsel Raises Stake in Merck & Co., Inc. $MRK - MarketBeat
Guggenheim Adjusts Price Target on Merck & Co to $140 From $122, Maintains Buy Rating - marketscreener.com
Merck & Co., Inc. $MRK Holdings Cut by Fishman Jay A Ltd. MI - MarketBeat
Bessemer Group Inc. Grows Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Price Up 1.1% on Analyst Upgrade - MarketBeat
Scotiabank Lifts Merck (MRK) Target as Execution Continues to Impress - Finviz
Merck stock rises 2% in New York as MRK traders size up outlook and a fresh RSV approval - TechStock²
Merck veteran Perlmutter-led Eikon Therapeutics valued at $860 million in Nasdaq debut - Reuters
Savant Capital LLC Boosts Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Triglav Investments D.O.O. - MarketBeat
Envestnet Asset Management Inc. Decreases Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
ABN AMRO Bank N.V. Acquires 37,932 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Holdings Lowered by Homestead Advisers Corp - MarketBeat
Merck & Co., Inc. $MRK Position Increased by BI Asset Management Fondsmaeglerselskab A S - MarketBeat
Merck Veteran-Led Eikon Therapeutics Raises $381 Million in IPO - Bloomberg
Merck & Co., Inc. (NYSE:MRK) Trading 2.2% Higher Following Earnings Beat - MarketBeat
Where is Merck & Co. (MRK) headed according to Wall Street? - MSN
Jim Cramer on Merck & Co.: “This is one of my favorite pharmaceutical stocks” - MSN
Jim Cramer on Merck & Co.: "This Is One of My Favorite Pharmaceutical Stocks" - Finviz
Jim Cramer on Merck & Co.: “This Is One of My Favorite Pharmaceutical Stocks” - Yahoo Finance
Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $120.00 at Citigroup - MarketBeat
Merck & Co Inc (NYSE:MRK) Tops Estimates - FXDailyReport.Com
Looking Into Merck & Co Inc's Recent Short Interest - Benzinga
Cantor Fitzgerald Forecasts Strong Price Appreciation for Merck & Co., Inc. (NYSE:MRK) Stock - MarketBeat
Wells Fargo & Company Forecasts Strong Price Appreciation for Merck & Co., Inc. (NYSE:MRK) Stock - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Q4 2025 Earnings Call Transcript - Insider Monkey
Ashton Thomas Private Wealth LLC Acquires 43,047 Shares of Merck & Co., Inc. $MRK - MarketBeat
Citigroup Adjusts Price Target on Merck & Co to $120 From $115, Maintains Neutral Rating - marketscreener.com
Payne Capital LLC Purchases Shares of 10,540 Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. Q4 Earnings Call Highlights - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Trading Up 2.2% on Earnings Beat - MarketBeat
Merck Looks Ahead To Phase III-Rich Period As Keytruda Winds Down - Citeline News & Insights
Merck & Co Inc (MRK) Q4 2025 Earnings Call Highlights: Strong Gr - GuruFocus
AI for investors - MLQ.ai
Merck Bats Away ‘Modest Growth’ Accusations, Touts Broad Pipeline - BioSpace
Merck's Annual Outlook Falls Short But Keytruda, Animal Health Segments Grow - Benzinga
Merck & Co., Inc. Provides Earnings Guidance for the Full Year 2026 - marketscreener.com
Finanzdaten der Merck Co Inc-Aktie (MRK)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):